LISATA THERAPEUTICS, INC. - LSTA
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$1.68M
QoQ value delta ($000)
+$332K
(+24.63%)
Implied price effect (QoQ)
+26.24%
Shares
Total shares
705,947
QoQ shares delta
-9,122
(-1.28%)
Total shares held by funds (by quarter)
Market chart (LSTA)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 8 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 503 | 270,909 | 0.0% |
| DELTEC ASSET MANAGEMENT LLC | 450 | 90,000 | 0.08% |
| RENAISSANCE TECHNOLOGIES LLC | 230 | 123,715 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 119 | 64,428 | 0.0% |
| BlackRock, Inc. | 102 | 54,857 | 0.0% |
| HighTower Advisors, LLC | 50 | 10,042 | 0.0% |
| Cerity Partners LLC | 49 | 12,183 | 0.0% |
| SOL Capital Management CO | 29 | 12,175 | 0.01% |
| STATE STREET CORP | 26 | 14,348 | 0.0% |
| DIMENSIONAL FUND ADVISORS LP | 26 | 14,253 | 0.0% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 25 | 5,000 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 19 | 10,418 | 0.0% |
| NORTHERN TRUST CORP | 19 | 10,268 | 0.0% |
| ROYAL BANK OF CANADA | 11 | 5,913 | 0.0% |
| UBS Group AG | 9 | 1,909 | 0.0% |
| Founders Capital Management | 8 | 1,667 | 0.0% |
| Tower Research Capital LLC (TRC) | 4 | 2,552 | 0.0% |
| Connective Capital Management, LLC | 1 | 1,016 | 0.0% |
| FMR LLC | 0 | 0 | 0.0% |
| CITIGROUP INC | 0 | 1 | 0.0% |
| MORGAN STANLEY | 0 | 75 | 0.0% |
| Cheviot Value Management, LLC | 0 | 3 | 0.0% |
| NewEdge Advisors, LLC | 0 | 107 | 0.0% |
| OSAIC HOLDINGS, INC. | 0 | 100 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 7 | 0.0% |